We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.51B
AUM Growth
-$25.3M
Cap. Flow
-$166M
Cap. Flow %
-11.02%
Top 10 Hldgs %
21.48%
Holding
1,502
New
400
Increased
305
Reduced
321
Closed
403

Top Buys

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$11.8M
2
EDU icon
New Oriental
EDU
+$11.7M
3
LI icon
Li Auto
LI
+$10.4M
4
HES
Hess
HES
+$9.96M
5
ACMR icon
ACM Research
ACMR
+$7.73M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$20.8M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$15.7M
3
TCOM icon
Trip.com Group
TCOM
+$13.1M
4
NEWR
New Relic, Inc.
NEWR
+$11.2M
5
VMW
VMware, Inc
VMW
+$9.66M

Sector Composition

Rank Sector Weight
1 Technology 14.24%
2 Consumer Discretionary 12.06%
3 Healthcare 10.13%
4 Industrials 10.12%
5 Energy 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDKRW
1101
Kodiak AI Warrants
KDKRW
– –
-100,590
Closed -$23.6K
ACDC icon
1102
ProFrac Holding
ACDC
$871M
– –
-21,076
Closed -$229K
ACEL icon
1103
Accel Entertainment
ACEL
$974M
– –
-10,247
Closed -$112K
ACHV icon
1104
Achieve Life Sciences
ACHV
$689M
– –
-25,429
Closed -$109K
ACIC icon
1105
American Coastal Insurance
ACIC
$476M
– –
-11,631
Closed -$85.6K
ADP icon
1106
Automatic Data Processing
ADP
$108B
– –
-1,372
Closed -$330K
ADPT icon
1107
Adaptive Biotechnologies
ADPT
$4.1B
– –
-13,156
Closed -$71.7K
ADSK icon
1108
Autodesk
ADSK
$53.7B
– –
-2,008
Closed -$415K
AIR icon
1109
AAR Corp
AIR
$5.83B
– –
-5,619
Closed -$334K
AKRO
1110
DELISTED
Akero Therapeutics
AKRO
– –
-11,243
Closed -$569K
ALC icon
1111
Alcon
ALC
$35.2B
– –
-12,140
Closed -$936K
ALT icon
1112
Altimmune
ALT
$587M
– –
-12,600
Closed -$32.8K
ALXO icon
1113
ALX Oncology
ALXO
$290M
– –
-10,900
Closed -$52.3K
AMG icon
1114
Affiliated Managers Group
AMG
$9.8B
– –
-1,605
Closed -$209K
AMLX icon
1115
Amylyx Pharmaceuticals
AMLX
$2.49B
– –
-16,600
Closed -$304K
AMP icon
1116
Ameriprise Financial
AMP
$49.6B
– –
-869
Closed -$286K
AMT icon
1117
CALL
American Tower
AMT
$79B
– –
-20,000
Closed -$3.29M
ANNX icon
1118
Annexon
ANNX
$890M
– –
-75,600
Closed -$178K
APAM icon
1119
Artisan Partners
APAM
$3.02B
– –
-7,078
Closed -$265K
APEI icon
1120
American Public Education
APEI
$943M
– –
-16,664
Closed -$83K
APLT
1121
DELISTED
Applied Therapeutics
APLT
– –
-63,508
Closed -$158K
APOG icon
1122
Apogee Enterprises
APOG
$884M
– –
-6,244
Closed -$294K
APPF icon
1123
AppFolio
APPF
$7.04B
– –
-1,408
Closed -$257K
AR icon
1124
Antero Resources
AR
$11.2B
– –
-21,484
Closed -$545K
ARCB icon
1125
ArcBest
ARCB
$3.07B
– –
-2,047
Closed -$208K
43 44
45
46 47

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Prelude Capital Management held 1,502 positions worth $1.51B, down 1.6% from $1.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Prelude Capital Management withdrew a net $166M in Q4 2023, closing 403 positions and reducing 321 holdings. Its most notable exit was Activision Blizzard, an estimated $20.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in New Oriental worth $12.4M.

  • Prelude Capital Management's largest Q4 2023 buy was New Oriental: 168,713 shares worth $12.4M.
  • Prelude Capital Management added most to Vipshop in Q4 2023, an estimated $11.8M increase.
  • Prelude Capital Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $7.3M.
  • Prelude Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $20.8M.
  • Prelude Capital Management's ten largest holdings make up 21% of its $1.51B portfolio in Q4 2023.
  • Prelude Capital Management opened 400 new positions and closed 403 in Q4 2023.
  • Prelude Capital Management's portfolio value fell 1.6% quarter-over-quarter to $1.51B.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.